Distribution and Drug Resistance of Bacterial Pathogens Associated with Lower Respiratory Tract Infection in Children and the Effect of COVID-19 on the Distribution of Pathogens
By studying the distribution and drug resistance of bacterial pathogens associated with lower respiratory tract infection (LRTI) in children in Chengdu and the effect of the COVID-19 on the distribution of pathogens and by analyzing the epidemic trend and drug resistance changes of the main pathogen...
Saved in:
Published in | The Canadian journal of infectious diseases & medical microbiology Vol. 2022; pp. 1 - 17 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Egypt
Hindawi
29.03.2022
John Wiley & Sons, Inc Wiley |
Subjects | |
Online Access | Get full text |
ISSN | 1712-9532 1918-1493 |
DOI | 10.1155/2022/1181283 |
Cover
Abstract | By studying the distribution and drug resistance of bacterial pathogens associated with lower respiratory tract infection (LRTI) in children in Chengdu and the effect of the COVID-19 on the distribution of pathogens and by analyzing the epidemic trend and drug resistance changes of the main pathogens of LRTI, this research is supposed to provide a useful basis for the prevention of LRTI in children and the rational use of drugs in clinical practice. Hospitalized children clinically diagnosed with LRTI in Chengdu Women and Children’s Central Hospital from 2011 to 2020 were selected as the study subjects. The pathogens of LRTI in children and the distribution of pathogens in different ages, genders, seasons, years, and departments and before and after the pandemic situation of COVID-19 were counted. The drug resistance distribution of the top six pathogens with the highest infection rate in the past three years and the trend of drug resistance in the past decade were analyzed. A total of 26,469 pathogens were isolated. Among them, 6240 strains (23.6%) were Gram-positive bacteria, 20152 strains (76.1%) were Gram-negative bacteria, and 73 strains (0.3%) were fungi. Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae, and Staphylococcus aureus were highly isolated in the group of infants aged 0-1 P<0.01, Moraxella catarrhalis and Streptococcus pneumoniae were highly isolated in children aged 1–6 P<0.01, and Haemophilus influenzae was highly isolated in children over 1 P<0.01. The isolation rates of Enterobacteriaceae, Acinetobacter baumannii, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Staphylococcus aureus, and Candida albicans in the lower respiratory tract of 0-1 year-old male infants were higher than those of female infants p<0.05. Haemophilus influenzae was highly isolated in spring and summer, and Moraxella catarrhalis was highly isolated in autumn and winter, while the infection of Streptococcus pneumoniae was mainly concentrated in winter. This difference was statistically significant P<0.01. Affected by the COVID-19 pandemic, the isolation rates of Haemophilus influenzae and Streptococcus pneumoniae were significantly lower than those before the pandemic, and the isolation rate of Moraxella catarrhalis was significantly higher. The difference was statistically significant P<0.01. The proportion of isolated negative bacteria in NICU and PICU was higher than that in positive bacteria, and the infection rates of Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae, and Acinetobacter baumannii were higher than those in other departments. The differences were statistically significant P<0.01. The results of drug sensitivity test showed that the drug resistance of Haemophilus influenzae and Moraxella catarrhalis was mainly concentrated in Ampicillin, First- and Second-generation cephalosporins, and Cotrimoxazole, with stable sensitivity to Third-generation cephalosporins, while the drug resistance of Streptococcus pneumoniae was concentrated in Macrolides, Sulfonamides, and Tetracyclines, with stable sensitivity to Penicillin. Staphylococcus aureus is highly resistant to penicillins and macrolides and susceptible to vancomycin. Enterobacteriaceae resistance is concentrated in cephalosporins, with a low rate of carbapenem resistance. From 2018 to 2020, 1557 strains of Staphylococcus aureus were isolated, of which 416 strains were MRSA, accounting for 27% of the isolates; 1064 strains of Escherichia coli were isolated, of which 423 strains were ESBL and 23 strains were CRE, accounting for 40% and 2% of the isolates, respectively; and 1400 strains of Klebsiella pneumoniae were isolated, of which 385 strains were ESBL and 402 strains were CRE, accounting for 28% and 29% of the isolates, respectively. Since 2011, the resistance of Escherichia coli and Klebsiella pneumoniae to Third-generation cephalosporins has increased, peaking in 2017, and has decreased after 2018, years after which carbapenem resistance has increased significantly, corresponding to an increase in the detection rate of Carbapenem-resistant Enterobacteriaceae CRE. Findings from this study revealed that there are significant differences in community-associated infectious pathogens before and after the COVID-19 pandemic, and there are significant age differences, seasonal epidemic trends, and high departmental correlation of pathogens related to lower respiratory tract disease infection in children. There was a significant gender difference in the isolation rate of pathogens associated with LRTI in infants under one year. Vaccination, implementation of isolation measures and social distance, strengthening of personal protective measures, aseptic operation of invasive medical treatment, hand hygiene, and environmental disinfection are beneficial to reducing community-associated pathogen infection, opportunistic pathogen infection, and an increase in resistant bacteria. The strengthening of bacterial culture of lower respiratory tract samples by pediatricians is conducive to the diagnosis of respiratory tract infections caused by different pathogens, contributing to the selection of effective drugs for treatment according to drug susceptibility results, which is important for the rational use of antibiotics and curbing bacterial resistance. |
---|---|
AbstractList | By studying the distribution and drug resistance of bacterial pathogens associated with lower respiratory tract infection (LRTI) in children in Chengdu and the effect of the COVID-19 on the distribution of pathogens and by analyzing the epidemic trend and drug resistance changes of the main pathogens of LRTI, this research is supposed to provide a useful basis for the prevention of LRTI in children and the rational use of drugs in clinical practice. Hospitalized children clinically diagnosed with LRTI in Chengdu Women and Children's Central Hospital from 2011 to 2020 were selected as the study subjects. The pathogens of LRTI in children and the distribution of pathogens in different ages, genders, seasons, years, and departments and before and after the pandemic situation of COVID-19 were counted. The drug resistance distribution of the top six pathogens with the highest infection rate in the past three years and the trend of drug resistance in the past decade were analyzed. A total of 26,469 pathogens were isolated. Among them, 6240 strains (23.6%) were Gram-positive bacteria, 20152 strains (76.1%) were Gram-negative bacteria, and 73 strains (0.3%) were fungi. Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae, and Staphylococcus aureus were highly isolated in the group of infants aged 0-1 (P<0.01), Moraxella catarrhalis and Streptococcus pneumoniae were highly isolated in children aged 1-6 (P<0.01), and Haemophilus influenzae was highly isolated in children over 1 (P<0.01). The isolation rates of Enterobacteriaceae, Acinetobacter baumannii, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Staphylococcus aureus, and Candida albicans in the lower respiratory tract of 0-1 year-old male infants were higher than those of female infants (p<0.05). Haemophilus influenzae was highly isolated in spring and summer, and Moraxella catarrhalis was highly isolated in autumn and winter, while the infection of Streptococcus pneumoniae was mainly concentrated in winter. This difference was statistically significant (P<0.01). Affected by the COVID-19 pandemic, the isolation rates of Haemophilus influenzae and Streptococcus pneumoniae were significantly lower than those before the pandemic, and the isolation rate of Moraxella catarrhalis was significantly higher. The difference was statistically significant (P<0.01). The proportion of isolated negative bacteria in NICU and PICU was higher than that in positive bacteria, and the infection rates of Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae, and Acinetobacter baumannii were higher than those in other departments. The differences were statistically significant (P<0.01). The results of drug sensitivity test showed that the drug resistance of Haemophilus influenzae and Moraxella catarrhalis was mainly concentrated in Ampicillin, First- and Second-generation cephalosporins, and Cotrimoxazole, with stable sensitivity to Third-generation cephalosporins, while the drug resistance of Streptococcus pneumoniae was concentrated in Macrolides, Sulfonamides, and Tetracyclines, with stable sensitivity to Penicillin. Staphylococcus aureus is highly resistant to penicillins and macrolides and susceptible to vancomycin. Enterobacteriaceae resistance is concentrated in cephalosporins, with a low rate of carbapenem resistance. From 2018 to 2020, 1557 strains of Staphylococcus aureus were isolated, of which 416 strains were MRSA, accounting for 27% of the isolates; 1064 strains of Escherichia coli were isolated, of which 423 strains were ESBL and 23 strains were CRE, accounting for 40% and 2% of the isolates, respectively; and 1400 strains of Klebsiella pneumoniae were isolated, of which 385 strains were ESBL and 402 strains were CRE, accounting for 28% and 29% of the isolates, respectively. Since 2011, the resistance of Escherichia coli and Klebsiella pneumoniae to Third-generation cephalosporins has increased, peaking in 2017, and has decreased after 2018, years after which carbapenem resistance has increased significantly, corresponding to an increase in the detection rate of Carbapenem-resistant Enterobacteriaceae CRE. Findings from this study revealed that there are significant differences in community-associated infectious pathogens before and after the COVID-19 pandemic, and there are significant age differences, seasonal epidemic trends, and high departmental correlation of pathogens related to lower respiratory tract disease infection in children. There was a significant gender difference in the isolation rate of pathogens associated with LRTI in infants under one year. Vaccination, implementation of isolation measures and social distance, strengthening of personal protective measures, aseptic operation of invasive medical treatment, hand hygiene, and environmental disinfection are beneficial to reducing community-associated pathogen infection, opportunistic pathogen infection, and an increase in resistant bacteria. The strengthening of bacterial culture of lower respiratory tract samples by pediatricians is conducive to the diagnosis of respiratory tract infections caused by different pathogens, contributing to the selection of effective drugs for treatment according to drug susceptibility results, which is important for the rational use of antibiotics and curbing bacterial resistance. By studying the distribution and drug resistance of bacterial pathogens associated with lower respiratory tract infection (LRTI) in children in Chengdu and the effect of the COVID-19 on the distribution of pathogens and by analyzing the epidemic trend and drug resistance changes of the main pathogens of LRTI, this research is supposed to provide a useful basis for the prevention of LRTI in children and the rational use of drugs in clinical practice. Hospitalized children clinically diagnosed with LRTI in Chengdu Women and Children's Central Hospital from 2011 to 2020 were selected as the study subjects. The pathogens of LRTI in children and the distribution of pathogens in different ages, genders, seasons, years, and departments and before and after the pandemic situation of COVID-19 were counted. The drug resistance distribution of the top six pathogens with the highest infection rate in the past three years and the trend of drug resistance in the past decade were analyzed. A total of 26,469 pathogens were isolated. Among them, 6240 strains (23.6%) were Gram-positive bacteria, 20152 strains (76.1%) were Gram-negative bacteria, and 73 strains (0.3%) were fungi. , , , were highly isolated in the group of infants aged 0-1 ( < 0.01), and were highly isolated in children aged 1-6 ( < 0.01), and was highly isolated in children over 1 ( < 0.01). The isolation rates of , , , , and in the lower respiratory tract of 0-1 year-old male infants were higher than those of female infants ( < 0.05). was highly isolated in spring and summer, and was highly isolated in autumn and winter, while the infection of was mainly concentrated in winter. This difference was statistically significant ( < 0.01). Affected by the COVID-19 pandemic, the isolation rates of and were significantly lower than those before the pandemic, and the isolation rate of was significantly higher. The difference was statistically significant ( < 0.01). The proportion of isolated negative bacteria in NICU and PICU was higher than that in positive bacteria, and the infection rates of , , and were higher than those in other departments. The differences were statistically significant ( < 0.01). The results of drug sensitivity test showed that the drug resistance of and was mainly concentrated in Ampicillin, First- and Second-generation cephalosporins, and Cotrimoxazole, with stable sensitivity to Third-generation cephalosporins, while the drug resistance of was concentrated in Macrolides, Sulfonamides, and Tetracyclines, with stable sensitivity to Penicillin. is highly resistant to penicillins and macrolides and susceptible to vancomycin. resistance is concentrated in cephalosporins, with a low rate of carbapenem resistance. From 2018 to 2020, 1557 strains of were isolated, of which 416 strains were MRSA, accounting for 27% of the isolates; 1064 strains of were isolated, of which 423 strains were ESBL and 23 strains were CRE, accounting for 40% and 2% of the isolates, respectively; and 1400 strains of were isolated, of which 385 strains were ESBL and 402 strains were CRE, accounting for 28% and 29% of the isolates, respectively. Since 2011, the resistance of and to Third-generation cephalosporins has increased, peaking in 2017, and has decreased after 2018, years after which carbapenem resistance has increased significantly, corresponding to an increase in the detection rate of CRE. Findings from this study revealed that there are significant differences in community-associated infectious pathogens before and after the COVID-19 pandemic, and there are significant age differences, seasonal epidemic trends, and high departmental correlation of pathogens related to lower respiratory tract disease infection in children. There was a significant gender difference in the isolation rate of pathogens associated with LRTI in infants under one year. Vaccination, implementation of isolation measures and social distance, strengthening of personal protective measures, aseptic operation of invasive medical treatment, hand hygiene, and environmental disinfection are beneficial to reducing community-associated pathogen infection, opportunistic pathogen infection, and an increase in resistant bacteria. The strengthening of bacterial culture of lower respiratory tract samples by pediatricians is conducive to the diagnosis of respiratory tract infections caused by different pathogens, contributing to the selection of effective drugs for treatment according to drug susceptibility results, which is important for the rational use of antibiotics and curbing bacterial resistance. By studying the distribution and drug resistance of bacterial pathogens associated with lower respiratory tract infection (LRTI) in children in Chengdu and the effect of the COVID-19 on the distribution of pathogens and by analyzing the epidemic trend and drug resistance changes of the main pathogens of LRTI, this research is supposed to provide a useful basis for the prevention of LRTI in children and the rational use of drugs in clinical practice. Hospitalized children clinically diagnosed with LRTI in Chengdu Women and Children’s Central Hospital from 2011 to 2020 were selected as the study subjects. The pathogens of LRTI in children and the distribution of pathogens in different ages, genders, seasons, years, and departments and before and after the pandemic situation of COVID-19 were counted. The drug resistance distribution of the top six pathogens with the highest infection rate in the past three years and the trend of drug resistance in the past decade were analyzed. A total of 26,469 pathogens were isolated. Among them, 6240 strains (23.6%) were Gram-positive bacteria, 20152 strains (76.1%) were Gram-negative bacteria, and 73 strains (0.3%) were fungi. Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae, and Staphylococcus aureus were highly isolated in the group of infants aged 0-1 P < 0.01 , Moraxella catarrhalis and Streptococcus pneumoniae were highly isolated in children aged 1–6 P < 0.01 , and Haemophilus influenzae was highly isolated in children over 1 P < 0.01 . The isolation rates of Enterobacteriaceae, Acinetobacter baumannii, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Staphylococcus aureus, and Candida albicans in the lower respiratory tract of 0-1 year-old male infants were higher than those of female infants p < 0.05 . Haemophilus influenzae was highly isolated in spring and summer, and Moraxella catarrhalis was highly isolated in autumn and winter, while the infection of Streptococcus pneumoniae was mainly concentrated in winter. This difference was statistically significant P < 0.01 . Affected by the COVID-19 pandemic, the isolation rates of Haemophilus influenzae and Streptococcus pneumoniae were significantly lower than those before the pandemic, and the isolation rate of Moraxella catarrhalis was significantly higher. The difference was statistically significant P < 0.01 . The proportion of isolated negative bacteria in NICU and PICU was higher than that in positive bacteria, and the infection rates of Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae, and Acinetobacter baumannii were higher than those in other departments. The differences were statistically significant P < 0.01 . The results of drug sensitivity test showed that the drug resistance of Haemophilus influenzae and Moraxella catarrhalis was mainly concentrated in Ampicillin, First- and Second-generation cephalosporins, and Cotrimoxazole, with stable sensitivity to Third-generation cephalosporins, while the drug resistance of Streptococcus pneumoniae was concentrated in Macrolides, Sulfonamides, and Tetracyclines, with stable sensitivity to Penicillin. Staphylococcus aureus is highly resistant to penicillins and macrolides and susceptible to vancomycin. Enterobacteriaceae resistance is concentrated in cephalosporins, with a low rate of carbapenem resistance. From 2018 to 2020, 1557 strains of Staphylococcus aureus were isolated, of which 416 strains were MRSA, accounting for 27% of the isolates; 1064 strains of Escherichia coli were isolated, of which 423 strains were ESBL and 23 strains were CRE, accounting for 40% and 2% of the isolates, respectively; and 1400 strains of Klebsiella pneumoniae were isolated, of which 385 strains were ESBL and 402 strains were CRE, accounting for 28% and 29% of the isolates, respectively. Since 2011, the resistance of Escherichia coli and Klebsiella pneumoniae to Third-generation cephalosporins has increased, peaking in 2017, and has decreased after 2018, years after which carbapenem resistance has increased significantly, corresponding to an increase in the detection rate of Carbapenem-resistant Enterobacteriaceae CRE. Findings from this study revealed that there are significant differences in community-associated infectious pathogens before and after the COVID-19 pandemic, and there are significant age differences, seasonal epidemic trends, and high departmental correlation of pathogens related to lower respiratory tract disease infection in children. There was a significant gender difference in the isolation rate of pathogens associated with LRTI in infants under one year. Vaccination, implementation of isolation measures and social distance, strengthening of personal protective measures, aseptic operation of invasive medical treatment, hand hygiene, and environmental disinfection are beneficial to reducing community-associated pathogen infection, opportunistic pathogen infection, and an increase in resistant bacteria. The strengthening of bacterial culture of lower respiratory tract samples by pediatricians is conducive to the diagnosis of respiratory tract infections caused by different pathogens, contributing to the selection of effective drugs for treatment according to drug susceptibility results, which is important for the rational use of antibiotics and curbing bacterial resistance. By studying the distribution and drug resistance of bacterial pathogens associated with lower respiratory tract infection (LRTI) in children in Chengdu and the effect of the COVID-19 on the distribution of pathogens and by analyzing the epidemic trend and drug resistance changes of the main pathogens of LRTI, this research is supposed to provide a useful basis for the prevention of LRTI in children and the rational use of drugs in clinical practice. Hospitalized children clinically diagnosed with LRTI in Chengdu Women and Children's Central Hospital from 2011 to 2020 were selected as the study subjects. The pathogens of LRTI in children and the distribution of pathogens in different ages, genders, seasons, years, and departments and before and after the pandemic situation of COVID-19 were counted. The drug resistance distribution of the top six pathogens with the highest infection rate in the past three years and the trend of drug resistance in the past decade were analyzed. A total of 26,469 pathogens were isolated. Among them, 6240 strains (23.6%) were Gram-positive bacteria, 20152 strains (76.1%) were Gram-negative bacteria, and 73 strains (0.3%) were fungi. Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae, and Staphylococcus aureus were highly isolated in the group of infants aged 0-1 (P < 0.01), Moraxella catarrhalis and Streptococcus pneumoniae were highly isolated in children aged 1-6 (P < 0.01), and Haemophilus influenzae was highly isolated in children over 1 (P < 0.01). The isolation rates of Enterobacteriaceae, Acinetobacter baumannii, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Staphylococcus aureus, and Candida albicans in the lower respiratory tract of 0-1 year-old male infants were higher than those of female infants (p < 0.05). Haemophilus influenzae was highly isolated in spring and summer, and Moraxella catarrhalis was highly isolated in autumn and winter, while the infection of Streptococcus pneumoniae was mainly concentrated in winter. This difference was statistically significant (P < 0.01). Affected by the COVID-19 pandemic, the isolation rates of Haemophilus influenzae and Streptococcus pneumoniae were significantly lower than those before the pandemic, and the isolation rate of Moraxella catarrhalis was significantly higher. The difference was statistically significant (P < 0.01). The proportion of isolated negative bacteria in NICU and PICU was higher than that in positive bacteria, and the infection rates of Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae, and Acinetobacter baumannii were higher than those in other departments. The differences were statistically significant (P < 0.01). The results of drug sensitivity test showed that the drug resistance of Haemophilus influenzae and Moraxella catarrhalis was mainly concentrated in Ampicillin, First- and Second-generation cephalosporins, and Cotrimoxazole, with stable sensitivity to Third-generation cephalosporins, while the drug resistance of Streptococcus pneumoniae was concentrated in Macrolides, Sulfonamides, and Tetracyclines, with stable sensitivity to Penicillin. Staphylococcus aureus is highly resistant to penicillins and macrolides and susceptible to vancomycin. Enterobacteriaceae resistance is concentrated in cephalosporins, with a low rate of carbapenem resistance. From 2018 to 2020, 1557 strains of Staphylococcus aureus were isolated, of which 416 strains were MRSA, accounting for 27% of the isolates; 1064 strains of Escherichia coli were isolated, of which 423 strains were ESBL and 23 strains were CRE, accounting for 40% and 2% of the isolates, respectively; and 1400 strains of Klebsiella pneumoniae were isolated, of which 385 strains were ESBL and 402 strains were CRE, accounting for 28% and 29% of the isolates, respectively. Since 2011, the resistance of Escherichia coli and Klebsiella pneumoniae to Third-generation cephalosporins has increased, peaking in 2017, and has decreased after 2018, years after which carbapenem resistance has increased significantly, corresponding to an increase in the detection rate of Carbapenem-resistant Enterobacteriaceae CRE. Findings from this study revealed that there are significant differences in community-associated infectious pathogens before and after the COVID-19 pandemic, and there are significant age differences, seasonal epidemic trends, and high departmental correlation of pathogens related to lower respiratory tract disease infection in children. There was a significant gender difference in the isolation rate of pathogens associated with LRTI in infants under one year. Vaccination, implementation of isolation measures and social distance, strengthening of personal protective measures, aseptic operation of invasive medical treatment, hand hygiene, and environmental disinfection are beneficial to reducing community-associated pathogen infection, opportunistic pathogen infection, and an increase in resistant bacteria. The strengthening of bacterial culture of lower respiratory tract samples by pediatricians is conducive to the diagnosis of respiratory tract infections caused by different pathogens, contributing to the selection of effective drugs for treatment according to drug susceptibility results, which is important for the rational use of antibiotics and curbing bacterial resistance.By studying the distribution and drug resistance of bacterial pathogens associated with lower respiratory tract infection (LRTI) in children in Chengdu and the effect of the COVID-19 on the distribution of pathogens and by analyzing the epidemic trend and drug resistance changes of the main pathogens of LRTI, this research is supposed to provide a useful basis for the prevention of LRTI in children and the rational use of drugs in clinical practice. Hospitalized children clinically diagnosed with LRTI in Chengdu Women and Children's Central Hospital from 2011 to 2020 were selected as the study subjects. The pathogens of LRTI in children and the distribution of pathogens in different ages, genders, seasons, years, and departments and before and after the pandemic situation of COVID-19 were counted. The drug resistance distribution of the top six pathogens with the highest infection rate in the past three years and the trend of drug resistance in the past decade were analyzed. A total of 26,469 pathogens were isolated. Among them, 6240 strains (23.6%) were Gram-positive bacteria, 20152 strains (76.1%) were Gram-negative bacteria, and 73 strains (0.3%) were fungi. Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae, and Staphylococcus aureus were highly isolated in the group of infants aged 0-1 (P < 0.01), Moraxella catarrhalis and Streptococcus pneumoniae were highly isolated in children aged 1-6 (P < 0.01), and Haemophilus influenzae was highly isolated in children over 1 (P < 0.01). The isolation rates of Enterobacteriaceae, Acinetobacter baumannii, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Staphylococcus aureus, and Candida albicans in the lower respiratory tract of 0-1 year-old male infants were higher than those of female infants (p < 0.05). Haemophilus influenzae was highly isolated in spring and summer, and Moraxella catarrhalis was highly isolated in autumn and winter, while the infection of Streptococcus pneumoniae was mainly concentrated in winter. This difference was statistically significant (P < 0.01). Affected by the COVID-19 pandemic, the isolation rates of Haemophilus influenzae and Streptococcus pneumoniae were significantly lower than those before the pandemic, and the isolation rate of Moraxella catarrhalis was significantly higher. The difference was statistically significant (P < 0.01). The proportion of isolated negative bacteria in NICU and PICU was higher than that in positive bacteria, and the infection rates of Klebsiella pneumoniae, Escherichia coli, Enterobacter cloacae, and Acinetobacter baumannii were higher than those in other departments. The differences were statistically significant (P < 0.01). The results of drug sensitivity test showed that the drug resistance of Haemophilus influenzae and Moraxella catarrhalis was mainly concentrated in Ampicillin, First- and Second-generation cephalosporins, and Cotrimoxazole, with stable sensitivity to Third-generation cephalosporins, while the drug resistance of Streptococcus pneumoniae was concentrated in Macrolides, Sulfonamides, and Tetracyclines, with stable sensitivity to Penicillin. Staphylococcus aureus is highly resistant to penicillins and macrolides and susceptible to vancomycin. Enterobacteriaceae resistance is concentrated in cephalosporins, with a low rate of carbapenem resistance. From 2018 to 2020, 1557 strains of Staphylococcus aureus were isolated, of which 416 strains were MRSA, accounting for 27% of the isolates; 1064 strains of Escherichia coli were isolated, of which 423 strains were ESBL and 23 strains were CRE, accounting for 40% and 2% of the isolates, respectively; and 1400 strains of Klebsiella pneumoniae were isolated, of which 385 strains were ESBL and 402 strains were CRE, accounting for 28% and 29% of the isolates, respectively. Since 2011, the resistance of Escherichia coli and Klebsiella pneumoniae to Third-generation cephalosporins has increased, peaking in 2017, and has decreased after 2018, years after which carbapenem resistance has increased significantly, corresponding to an increase in the detection rate of Carbapenem-resistant Enterobacteriaceae CRE. Findings from this study revealed that there are significant differences in community-associated infectious pathogens before and after the COVID-19 pandemic, and there are significant age differences, seasonal epidemic trends, and high departmental correlation of pathogens related to lower respiratory tract disease infection in children. There was a significant gender difference in the isolation rate of pathogens associated with LRTI in infants under one year. Vaccination, implement By studying the distribution and drug resistance of bacterial pathogens associated with lower respiratory tract infection (LRTI) in children in Chengdu and the effect of the COVID-19 on the distribution of pathogens and by analyzing the epidemic trend and drug resistance changes of the main pathogens of LRTI, this research is supposed to provide a useful basis for the prevention of LRTI in children and the rational use of drugs in clinical practice. Hospitalized children clinically diagnosed with LRTI in Chengdu Women and Children's Central Hospital from 2011 to 2020 were selected as the study subjects. The pathogens of LRTI in children and the distribution of pathogens in different ages, genders, seasons, years, and departments and before and after the pandemic situation of COVID-19 were counted. The drug resistance distribution of the top six pathogens with the highest infection rate in the past three years and the trend of drug resistance in the past decade were analyzed. A total of 26,469 pathogens were isolated. Among them, 6240 strains (23.6%) were Gram-positive bacteria, 20152 strains (76.1%) were Gram-negative bacteria, and 73 strains (0.3%) were fungi. Klebsiella pneumoniae , Escherichia coli , Enterobacter cloacae , and Staphylococcus aureus were highly isolated in the group of infants aged 0-1 ( P < 0.01), Moraxella catarrhalis and Streptococcus pneumoniae were highly isolated in children aged 1–6 ( P < 0.01), and Haemophilus influenzae was highly isolated in children over 1 ( P < 0.01). The isolation rates of Enterobacteriaceae , Acinetobacter baumannii , Pseudomonas aeruginosa , Stenotrophomonas maltophilia , Staphylococcus aureus, and Candida albicans in the lower respiratory tract of 0-1 year-old male infants were higher than those of female infants ( p < 0.05). Haemophilus influenzae was highly isolated in spring and summer, and Moraxella catarrhalis was highly isolated in autumn and winter, while the infection of Streptococcus pneumoniae was mainly concentrated in winter. This difference was statistically significant ( P < 0.01). Affected by the COVID-19 pandemic, the isolation rates of Haemophilus influenzae and Streptococcus pneumoniae were significantly lower than those before the pandemic, and the isolation rate of Moraxella catarrhalis was significantly higher. The difference was statistically significant ( P < 0.01). The proportion of isolated negative bacteria in NICU and PICU was higher than that in positive bacteria, and the infection rates of Klebsiella pneumoniae , Escherichia coli , Enterobacter cloacae, and Acinetobacter baumannii were higher than those in other departments. The differences were statistically significant ( P < 0.01). The results of drug sensitivity test showed that the drug resistance of Haemophilus influenzae and Moraxella catarrhalis was mainly concentrated in Ampicillin, First- and Second-generation cephalosporins, and Cotrimoxazole, with stable sensitivity to Third-generation cephalosporins, while the drug resistance of Streptococcus pneumoniae was concentrated in Macrolides, Sulfonamides, and Tetracyclines, with stable sensitivity to Penicillin. Staphylococcus aureus is highly resistant to penicillins and macrolides and susceptible to vancomycin. Enterobacteriaceae resistance is concentrated in cephalosporins, with a low rate of carbapenem resistance. From 2018 to 2020, 1557 strains of Staphylococcus aureus were isolated, of which 416 strains were MRSA, accounting for 27% of the isolates; 1064 strains of Escherichia coli were isolated, of which 423 strains were ESBL and 23 strains were CRE, accounting for 40% and 2% of the isolates, respectively; and 1400 strains of Klebsiella pneumoniae were isolated, of which 385 strains were ESBL and 402 strains were CRE, accounting for 28% and 29% of the isolates, respectively. Since 2011, the resistance of Escherichia coli and Klebsiella pneumoniae to Third-generation cephalosporins has increased, peaking in 2017, and has decreased after 2018, years after which carbapenem resistance has increased significantly, corresponding to an increase in the detection rate of Carbapenem-resistant Enterobacteriaceae CRE. Findings from this study revealed that there are significant differences in community-associated infectious pathogens before and after the COVID-19 pandemic, and there are significant age differences, seasonal epidemic trends, and high departmental correlation of pathogens related to lower respiratory tract disease infection in children. There was a significant gender difference in the isolation rate of pathogens associated with LRTI in infants under one year. Vaccination, implementation of isolation measures and social distance, strengthening of personal protective measures, aseptic operation of invasive medical treatment, hand hygiene, and environmental disinfection are beneficial to reducing community-associated pathogen infection, opportunistic pathogen infection, and an increase in resistant bacteria. The strengthening of bacterial culture of lower respiratory tract samples by pediatricians is conducive to the diagnosis of respiratory tract infections caused by different pathogens, contributing to the selection of effective drugs for treatment according to drug susceptibility results, which is important for the rational use of antibiotics and curbing bacterial resistance. |
Audience | Academic |
Author | Zhang, Liyuan Zhu, Xuan Song, Peipei Ye, Ting Xu, Jian Luo, Yaxuan Zhong, Hong Luo, Xiaobo Zhang, Qin Zhang, Jun Wang, Qin |
AuthorAffiliation | 2 Key Laboratory of Diagnostic Medicine Designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing 400016, China 1 Department of Clinical Laboratory, Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 611731, China 3 Department of Pediatric Hematology and Oncology Department, Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 611731, China |
AuthorAffiliation_xml | – name: 3 Department of Pediatric Hematology and Oncology Department, Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 611731, China – name: 2 Key Laboratory of Diagnostic Medicine Designated by the Chinese Ministry of Education, Chongqing Medical University, Chongqing 400016, China – name: 1 Department of Clinical Laboratory, Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 611731, China |
Author_xml | – sequence: 1 givenname: Xuan orcidid: 0000-0003-2657-6000 surname: Zhu fullname: Zhu, Xuan organization: Department of Clinical LaboratoryChengdu Women’s and Children’s Central HospitalSchool of MedicineUniversity of Electronic Science and Technology of ChinaChengdu 611731Chinauestc.edu.cn – sequence: 2 givenname: Ting surname: Ye fullname: Ye, Ting organization: Key Laboratory of Diagnostic Medicine Designated by the Chinese Ministry of EducationChongqing Medical UniversityChongqing 400016Chinacqmu.edu.cn – sequence: 3 givenname: Hong surname: Zhong fullname: Zhong, Hong organization: Department of Clinical LaboratoryChengdu Women’s and Children’s Central HospitalSchool of MedicineUniversity of Electronic Science and Technology of ChinaChengdu 611731Chinauestc.edu.cn – sequence: 4 givenname: Yaxuan surname: Luo fullname: Luo, Yaxuan organization: Department of Clinical LaboratoryChengdu Women’s and Children’s Central HospitalSchool of MedicineUniversity of Electronic Science and Technology of ChinaChengdu 611731Chinauestc.edu.cn – sequence: 5 givenname: Jian surname: Xu fullname: Xu, Jian organization: Department of Clinical LaboratoryChengdu Women’s and Children’s Central HospitalSchool of MedicineUniversity of Electronic Science and Technology of ChinaChengdu 611731Chinauestc.edu.cn – sequence: 6 givenname: Qin surname: Zhang fullname: Zhang, Qin organization: Department of Clinical LaboratoryChengdu Women’s and Children’s Central HospitalSchool of MedicineUniversity of Electronic Science and Technology of ChinaChengdu 611731Chinauestc.edu.cn – sequence: 7 givenname: Xiaobo surname: Luo fullname: Luo, Xiaobo organization: Department of Pediatric Hematology and Oncology DepartmentChengdu Women’s and Children’s Central HospitalSchool of MedicineUniversity of Electronic Science and Technology of ChinaChengdu 611731Chinauestc.edu.cn – sequence: 8 givenname: Qin orcidid: 0000-0002-1304-4753 surname: Wang fullname: Wang, Qin organization: Department of Clinical LaboratoryChengdu Women’s and Children’s Central HospitalSchool of MedicineUniversity of Electronic Science and Technology of ChinaChengdu 611731Chinauestc.edu.cn – sequence: 9 givenname: Liyuan surname: Zhang fullname: Zhang, Liyuan organization: Department of Clinical LaboratoryChengdu Women’s and Children’s Central HospitalSchool of MedicineUniversity of Electronic Science and Technology of ChinaChengdu 611731Chinauestc.edu.cn – sequence: 10 givenname: Peipei surname: Song fullname: Song, Peipei organization: Department of Clinical LaboratoryChengdu Women’s and Children’s Central HospitalSchool of MedicineUniversity of Electronic Science and Technology of ChinaChengdu 611731Chinauestc.edu.cn – sequence: 11 givenname: Jun surname: Zhang fullname: Zhang, Jun organization: Department of Clinical LaboratoryChengdu Women’s and Children’s Central HospitalSchool of MedicineUniversity of Electronic Science and Technology of ChinaChengdu 611731Chinauestc.edu.cn |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35368516$$D View this record in MEDLINE/PubMed |
BookMark | eNp9k91v0zAQwCM0xD7gjWdkMQkhQbdcPhznBal0AypVGkITr9bVsRtXqd3ZLtP-LP5DnLYb7TRQHhLd_e539sU-Tg6MNTJJXkN6BlCW51maZecADDKWP0uOoAY2gKLOD-J3BdmgLvPsMDn2fp6mOc2gepEc5mVOWQn0KPl9oX1weroK2hqCpiEXbjUjP6SPcTRCEqvIZxRBOo0d-Y6htTNpPBl6b4XGIBtyq0NLJvZWur5uqR0G6-7ItYtlZGyUFGu5NmTU6q5xctMotJJcqj7b9xhd_RxfDKAmkewze-uK-YfOL5PnCjsvX23fJ8n1l8vr0bfB5OrreDScDERJ6zBQhVKQUpZXFPIpKzFnSsRt05wKhcBEWikosQHFVMUiOMVCiAwFsqapWX6SjDfaxuKcL51eoLvjFjVfB6ybcXRBi07ytKgaUWeVmKa0qCGrUykrwUAWJYppCdH1aeNarqYL2QhpgsNuT7qfMbrlM_uLs5qWVV5EwfutwNmblfSBL7QXsuvQSLvyPKMFrQsKcXcnyekjdG5XzsRJ9RSLxyRif6kZxg1oo2zsK3opHzIogEVTP4O3T1BiqW_4LnT2BBSfRi60iGdV6Rjfs77bKWgldqH1tlv_ab8Pvtkd28O87k9vBLINIJz13knFhQ7Ye-ISdMch5f0V4f0V4dsrEos-Piq69_4D_7DBW20avNX_p_8A8_Mb6g |
CitedBy_id | crossref_primary_10_2147_IDR_S400207 crossref_primary_10_2147_IDR_S397513 crossref_primary_10_1002_hsr2_70214 crossref_primary_10_2147_IDR_S423580 crossref_primary_10_1016_j_ijmmb_2024_100742 crossref_primary_10_1007_s15010_024_02308_8 crossref_primary_10_1186_s13052_025_01859_2 crossref_primary_10_1038_s41598_024_62728_2 crossref_primary_10_1002_jmv_70063 crossref_primary_10_3390_microorganisms11102542 crossref_primary_10_1515_labmed_2022_0104 crossref_primary_10_1089_mdr_2024_0064 |
Cites_doi | 10.1093/ofid/ofaa307 10.1016/S2214-109X(19)30071-3 10.1186/s12879-015-1188-1 10.1093/cid/cir531 10.1016/s2214-109x(18)30491-1 10.1093/aje/kwu002 10.1016/j.vaccine.2017.11.018 10.3760/cma.j.issn.1001-0939.2018.04.007 10.1001/jamapediatrics.2021.4217 10.2478/jvetres-2020-0057 10.3389/fmicb.2020.575707 10.1016/j.cmi.2021.05.034 10.1007/s10096-018-3314-7 10.1016/S1473-3099(18)30310-4 10.3390/vaccines9050474 10.1371/journal.pone.0237871 10.1126/science.336.6083.795 10.1002/ppul.22661 10.1007/s00038-017-1007-0 10.1186/s12942-016-0061-9 10.1016/s0140-6736(12)61901-1 10.1136/bmj.l440 10.1093/jac/dkw332 10.1073/pnas.2004933118 10.1016/s1473-3099(16)30527-8 10.1016/s0140-6736(15)00474-2 10.1016/j.cmi.2020.04.033 10.1016/S1473-3099(17)30396-1 10.1371/journal.pone.0195098 10.1128/aac.00075-16 10.22038/ijorl.2019.34363.2137 10.1371/journal.pmed.1003208 10.1016/j.prrv.2020.06.016 10.1007/s40272-017-0257-x 10.1016/j.jiac.2016.11.001 10.1016/s2214-109x(20)30229-1 10.1016/j.envint.2019.105150 10.1038/s41587-019-0156-5 |
ContentType | Journal Article |
Copyright | Copyright © 2022 Xuan Zhu et al. COPYRIGHT 2022 John Wiley & Sons, Inc. Copyright © 2022 Xuan Zhu et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0 Copyright © 2022 Xuan Zhu et al. 2022 |
Copyright_xml | – notice: Copyright © 2022 Xuan Zhu et al. – notice: COPYRIGHT 2022 John Wiley & Sons, Inc. – notice: Copyright © 2022 Xuan Zhu et al. This is an open access article distributed under the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. https://creativecommons.org/licenses/by/4.0 – notice: Copyright © 2022 Xuan Zhu et al. 2022 |
DBID | RHU RHW RHX AAYXX CITATION NPM 3V. 7T7 7X7 7XB 8FD 8FI 8FJ 8FK 8FQ 8FV ABUWG AEUYN AFKRA AZQEC BENPR C1K CCPQU DWQXO FR3 FYUFA GHDGH K9. M0S P64 PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI Q9U 7X8 5PM DOA |
DOI | 10.1155/2022/1181283 |
DatabaseName | Hindawi Publishing Complete Hindawi Publishing Subscription Journals Hindawi Publishing Open Access CrossRef PubMed ProQuest Central (Corporate) Industrial and Applied Microbiology Abstracts (Microbiology A) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Technology Research Database ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Canadian Business & Current Affairs Database Canadian Business & Current Affairs Database (Alumni) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central Environmental Sciences and Pollution Management ProQuest One ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College Environmental Sciences and Pollution Management ProQuest Central CBCA Complete (Alumni Edition) ProQuest One Sustainability Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea CBCA Complete Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | PubMed CrossRef MEDLINE - Academic Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: RHX name: Hindawi Publishing Open Access url: http://www.hindawi.com/journals/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Public Health |
EISSN | 1918-1493 |
Editor | Manilal, Aseer |
Editor_xml | – sequence: 1 givenname: Aseer surname: Manilal fullname: Manilal, Aseer |
EndPage | 17 |
ExternalDocumentID | oai_doaj_org_article_047dc927cb06491290ee7c81e45acb51 PMC8965734 A814186638 35368516 10_1155_2022_1181283 |
Genre | Journal Article |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GrantInformation_xml | – fundername: Chengdu Women’s and Children’s Central Hospital – fundername: Sichuan Provincial Medical Youth Innovative Scientific Research Foundation of China grantid: Q20069 – fundername: Chengdu Women's and Children's Central Hospital |
GroupedDBID | --- 19Q 29B 3V. 53G 5GY 5VS 6J9 7X7 8FI 8FJ 8FQ AAFWJ AAIKC AAJEY AAMNW ABDBF ABUWG ACIHN ADBBV AEAQA AENEX AFKRA AFPKN AHMBA ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV BENPR BPHCQ BVXVI CCPQU DIK DWQXO E3Z EBS EJD FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO ICQ IHR INH ITC KQ8 OK1 P6G PIMPY PQQKQ PROAC RHU RHW RHX RPM TR2 TUS UKHRP 0R~ 24P AAYXX ACCMX ACUHS AEUYN CITATION IHW PHGZM PHGZT AAMMB AEFGJ AGXDD AIDQK AIDYY H13 IPNFZ NPM RIG PMFND 7T7 7XB 8FD 8FK AZQEC C1K FR3 K9. M~E P64 PKEHL PQEST PQUKI Q9U 7X8 PUEGO 5PM |
ID | FETCH-LOGICAL-c569t-f4ff106837613b85a38fc536636cfa18c07f15ad1f8f78068ba4cc2aca8dd983 |
IEDL.DBID | 7X7 |
ISSN | 1712-9532 |
IngestDate | Wed Aug 27 01:27:10 EDT 2025 Thu Aug 21 18:42:25 EDT 2025 Fri Sep 05 13:13:42 EDT 2025 Wed Aug 13 04:05:42 EDT 2025 Tue Jun 17 22:02:21 EDT 2025 Tue Jun 10 15:40:57 EDT 2025 Tue Jun 10 20:59:53 EDT 2025 Thu May 22 21:23:25 EDT 2025 Mon Jul 21 05:45:48 EDT 2025 Tue Jul 01 02:53:54 EDT 2025 Thu Apr 24 23:05:21 EDT 2025 Sun Jun 02 19:21:27 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
License | This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. https://creativecommons.org/licenses/by/4.0 Copyright © 2022 Xuan Zhu et al. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c569t-f4ff106837613b85a38fc536636cfa18c07f15ad1f8f78068ba4cc2aca8dd983 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Academic Editor: Aseer Manilal |
ORCID | 0000-0002-1304-4753 0000-0003-2657-6000 |
OpenAccessLink | https://www.proquest.com/docview/2648812616?pq-origsite=%requestingapplication% |
PMID | 35368516 |
PQID | 2648812616 |
PQPubID | 2032235 |
PageCount | 17 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_047dc927cb06491290ee7c81e45acb51 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8965734 proquest_miscellaneous_2646946166 proquest_journals_2648812616 gale_infotracmisc_A814186638 gale_infotraccpiq_814186638 gale_infotracacademiconefile_A814186638 gale_healthsolutions_A814186638 pubmed_primary_35368516 crossref_citationtrail_10_1155_2022_1181283 crossref_primary_10_1155_2022_1181283 hindawi_primary_10_1155_2022_1181283 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-03-29 |
PublicationDateYYYYMMDD | 2022-03-29 |
PublicationDate_xml | – month: 03 year: 2022 text: 2022-03-29 day: 29 |
PublicationDecade | 2020 |
PublicationPlace | Egypt |
PublicationPlace_xml | – name: Egypt – name: Oakville |
PublicationTitle | The Canadian journal of infectious diseases & medical microbiology |
PublicationTitleAlternate | Can J Infect Dis Med Microbiol |
PublicationYear | 2022 |
Publisher | Hindawi John Wiley & Sons, Inc Wiley |
Publisher_xml | – name: Hindawi – name: John Wiley & Sons, Inc – name: Wiley |
References | 22 GBD 2015 Eastern Mediterranean Region Lower Respiratory Infections Collaborators (4) 2018; 63 23 24 25 26 27 28 29 M. Pfeifer (5) 2020; 1–11 M. F. Zuo (31) 2014; 16 30 10 32 11 33 12 34 13 35 14 36 15 37 16 38 17 39 18 19 K. M. Hare (21) 2010; 53 1 2 3 6 7 8 9 40 41 20 |
References_xml | – ident: 20 doi: 10.1093/ofid/ofaa307 – ident: 14 doi: 10.1016/S2214-109X(19)30071-3 – ident: 22 doi: 10.1186/s12879-015-1188-1 – ident: 10 doi: 10.1093/cid/cir531 – ident: 23 doi: 10.1016/s2214-109x(18)30491-1 – ident: 29 doi: 10.1093/aje/kwu002 – ident: 1 doi: 10.1016/j.vaccine.2017.11.018 – ident: 30 doi: 10.3760/cma.j.issn.1001-0939.2018.04.007 – ident: 6 doi: 10.1001/jamapediatrics.2021.4217 – ident: 36 doi: 10.2478/jvetres-2020-0057 – ident: 37 doi: 10.3389/fmicb.2020.575707 – ident: 18 doi: 10.1016/j.cmi.2021.05.034 – ident: 19 doi: 10.1007/s10096-018-3314-7 – ident: 2 doi: 10.1016/S1473-3099(18)30310-4 – ident: 26 doi: 10.3390/vaccines9050474 – ident: 34 doi: 10.1371/journal.pone.0237871 – ident: 39 doi: 10.1126/science.336.6083.795 – ident: 13 doi: 10.1002/ppul.22661 – volume: 63 start-page: 97 issue: 1 year: 2018 ident: 4 article-title: Burden of lower respiratory infections in the eastern mediterranean region between 1990 and 2015: findings from the global burden of disease 2015 study publication-title: International Journal of Public Health doi: 10.1007/s00038-017-1007-0 – ident: 11 doi: 10.1186/s12942-016-0061-9 – volume: 16 start-page: 1226 issue: 12 year: 2014 ident: 31 article-title: [Pathologic bacterial distribution and antibiotic resistance in induced sputum of infants aged from 1 to 3 months with lower respiratory tract infection] publication-title: Chinese Journal of Contemporary Pediatrics – ident: 3 doi: 10.1016/s0140-6736(12)61901-1 – ident: 15 doi: 10.1136/bmj.l440 – ident: 33 doi: 10.1093/jac/dkw332 – ident: 25 doi: 10.1073/pnas.2004933118 – ident: 38 doi: 10.1016/s1473-3099(16)30527-8 – ident: 9 doi: 10.1016/s0140-6736(15)00474-2 – ident: 24 doi: 10.1016/j.cmi.2020.04.033 – ident: 12 doi: 10.1016/S1473-3099(17)30396-1 – ident: 17 doi: 10.1371/journal.pone.0195098 – volume: 53 start-page: 151 issue: 3-4 year: 2010 ident: 21 article-title: The bacteriology of lower respiratory infections in Papua New Guinean and Australian indigenous children publication-title: Papua New Guinea Medical Journal – ident: 40 doi: 10.1128/aac.00075-16 – ident: 32 doi: 10.22038/ijorl.2019.34363.2137 – ident: 16 doi: 10.1371/journal.pmed.1003208 – ident: 8 doi: 10.1016/j.prrv.2020.06.016 – ident: 27 doi: 10.1007/s40272-017-0257-x – ident: 35 doi: 10.1016/j.jiac.2016.11.001 – ident: 7 doi: 10.1016/s2214-109x(20)30229-1 – ident: 28 doi: 10.1016/j.envint.2019.105150 – ident: 41 doi: 10.1038/s41587-019-0156-5 – volume: 1–11 year: 2020 ident: 5 article-title: [COVID-19 pneumonia] publication-title: The Gastroenterologist: Zeitschrift fur Gastroenterologie und Hepatologie |
SSID | ssj0036217 |
Score | 2.333462 |
Snippet | By studying the distribution and drug resistance of bacterial pathogens associated with lower respiratory tract infection (LRTI) in children in Chengdu and the... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref hindawi |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1 |
SubjectTerms | Acinetobacter baumannii Age Age differences Ampicillin Antibiotics Bacteria Bacteria, Pathogenic Bacterial infections Cephalosporins Children Communicable diseases in children Cotrimoxazole COVID-19 Disease Disinfection Distribution Drug resistance Drug resistance in microorganisms E coli Enterobacter cloacae Enterobacteriaceae Epidemics Escherichia coli Gender Gram-negative bacteria Gram-positive bacteria Haemophilus influenzae Health services Hospitals Hygiene Infants Infectious diseases Klebsiella Klebsiella pneumoniae Laboratories Low income groups Medical prognosis Medical treatment Moraxella catarrhalis Mortality Opportunist infection Outdoor air quality Pandemics Pathogens Pediatric research Pediatrics Penicillin Personal hygiene Pneumonia Pseudomonas aeruginosa Public health Respiration Respiratory tract Respiratory tract diseases Respiratory tract infection Respiratory tract infections Risk factors Sensitivity Sensitivity analysis Software Staphylococcus aureus Statistical analysis Statistical methods Strengthening Streptococcus pneumoniae Sulfonamides Tetracyclines Trends Tuberculosis Vaccination Vancomycin Viral diseases Winter |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQJRAXxJulCxipiAOKmocd28d2l6pFFBAqqDfLT7oSypburvhd_ENmEifaIFAvXHfG69gzHs8kM98QssfzquQuD5kRnmfMmpgZX8dMhcCD4IWLHAucTz_Ux1_Yu3N-vtXqC3PCOnjgbuP2cya8U6VwFi5PhW9NQhBOFoFx42xbPF3mKu-Dqc4Gg1UuRJ_mzjlG-OU-lliWshpdQC1O_2CNb15gHPxz8Tdv88-kya1b6OguuZPcR3rQPfY9ciM098mt0_SB_AH5NUcg3NTDiprG0_nV5hv9HFboJ4KA6TLSww6hGf7nE_h_S1ChFe3FFDzFV7P0PXZPw3H9h3h6hvVU9CQlbzV00dBZqgRvJwJPknZYyDjH7OPXk3lWKAqcSBk9F9CHmR-Ss6O3Z7PjLHVlyByv1TqLLEaIIyGwBU_ASm4qGR2vwHOpXTSFdLmIBTe-iDIKCYzWMOdK44z0XsnqEdlplk14Qiiz3ltZWSNry2KFzklZK-WEK_MgXT0hb3pJaZcQy7FxxnfdRi6ca5SrTnKdkFcD92WH1PEPvkMU-sCD-NrtD6B1Ommdvk7rJuQFqozuilUHK6EPZMEQQrCSE_K65UA7AQ_tTCp3gKUj4taIc3fE6S4XP_QWdTqiwul3o8F7SWmvWfS012idjNRKY3IjUOsCdvrlQMYJMPGuCctNy1MrBizA87g7AMNEFcfuBThajI7GaGvHlGZx0UKYS1VzUbGn_0MWu-Q2LhUTA0s1JTvrq014Bp7i2j5vjcJvR4pkdQ priority: 102 providerName: Directory of Open Access Journals – databaseName: Hindawi Publishing Open Access dbid: RHX link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELfYJBAviO-VFTDSEA8oIk5sx37cWqYOMUBTQX2zHMdmlVA61lb8XfyH3CVOtAwQPCb3c-zkzudzfB-EHIg0z4RLfWKLSiS8tCGxlQyJ9l74QjAXBAY4n36Qs8_83UIsYpKk9e9H-LDa4fY8e4PxkbAS7pAdJVF4z2aLTuGCCm4K67KCZXgamXX-7dfaDlaeJkF_r4ZvnuMG-MfyT2bmdW_JK8vP8V1yJ9qN9LBl9D1yw9f3ya3TeDL-gPycYgbcWLyK2rqi08vtV3rm12ggAmfpKtCjNjUzPOcTGH4rkJ017fjjK4r_ZOl7LJuG7boTeDrHQCp6Er22arqs6SSGgDcdgQlJ2yTI2Mfk45eTacI0BSRSBuMCet_zQzI_fjufzJJYjiFxQupNEngIsIGEHS2YAKUSNlfBiRxMFumCZcqlRWDCViyoUCgAlpY7l1lnVVVplT8iu_Wq9nuE8rKqSpWXVsmShxytkkxq7QqXpV45OSKvO04ZF1OVY8WMb6bZsghhkK8m8nVEXvboizZFx19wR8j0HoOJtZsbIGwmzlOT8qJyOitcCbaaxp903hdOMc-FdaVgI_IcRca0Uaq9ejCHinHMHZirEXnVIFBBwKCdjXEO8OqYamuA3B8g3cXyu7lCHQ-oMO3doPFBFNp_vPS4k2gTtdPaoFcjUCWDL_2iJ2MH6HFX-9W2wUjNAQKYx-0E6DvKBZYtwNbFYGoMPu2QUi_Pm9zlSktR5PzJ_41-n9zGS_T5y_SY7G4ut_4pGIGb8lmjAn4BsYtT0w priority: 102 providerName: Hindawi Publishing |
Title | Distribution and Drug Resistance of Bacterial Pathogens Associated with Lower Respiratory Tract Infection in Children and the Effect of COVID-19 on the Distribution of Pathogens |
URI | https://dx.doi.org/10.1155/2022/1181283 https://www.ncbi.nlm.nih.gov/pubmed/35368516 https://www.proquest.com/docview/2648812616 https://www.proquest.com/docview/2646946166 https://pubmed.ncbi.nlm.nih.gov/PMC8965734 https://doaj.org/article/047dc927cb06491290ee7c81e45acb51 |
Volume | 2022 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhR1rb9Mw0IJNIKQJwXisrBQjDfEBRauTOHY-obXd1AIbU1VQv0WOY2-VUNL1IX4X_5C7xAkL4vGlUnrn2I7P57vzPQg54v3A57pvPCUy7oWpsp7KIuvFxnAjONOWY4Dz-UU0_hJ-mPO5M7itnVtlzRNLRp0VGm3kx-iJBYdRxKL3yxsPq0bh7aoroXGX7DKQRLB0g5g3Chfw5rLiLhPMx2tKv3Z85xx1fv8Ygy59GbSOpDJzf8Of712jZvx98Sf583c3ylvn0tkj8tAJlPSkooDH5I5d7ZP75-7KfJ_sVYY5WsUbPSE_Rpgq11W5oirP6Gi1vaJTs0ZJEkiAFpYOqhzO8N5LkBALILI1rRfSZBSNt_QT1lfDdvVVPZ1hxBWdOPeunC5yOnSx4mVHIGvSKlsy9jH8_HUy8lhMARMhrXEBvOn5KZmdnc6GY8_VbfA0j-KNZ0NrQdME1RdkhVRyFUireQCyTaStYlL3hWVcZcxKKyQgpirU2ldaySyLZfCM7ORFbg4IDdMsS2WQKhmloQ1QfPGjONZC-30jddQh7-qVS7TLaY6lNb4lpW7DeYLrnLh17pA3DfayyuXxF7wBEkGDgxm4yz-K1VXiNnTSD0WmY1_oFIS6GK15xggtmQm50ilnHfIKSSipwlkbPpKcSBZiksFAdsjbEgM5CQxaKxcQAVPHnFwtzMMWpl4ubpJb0G4LCvxBtxofOSL-z6S7NYUnjo2tk1-brkNeN2DsAF3zclNsS5woDgEFcJ5XG6LpKOBY3wBbi9ZWaX3aNiRfXJdJzmUccRGEL_49rEPyACeBToF-3CU7m9XWvAQpcZP2SlbQI7uD04vLKTyNJh97pcUFfqfj-U828Gew |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3bbtMw1BqduEgIwbiVFWakTTygaE1iJ87DhNZ2U8vaMk0F7c1yfNkqobTrRROfxQfwb_gkTlgQl6e99hzHdn18bj4XhHZpOwyobGtPxIp6JBXGEyoyXqI11TH1paGQ4DwaR_3P5OM5Pd9AP8pcGAirLHlizqjVTIKPfB8isawwivzow_zKg65R8LpattAQrrWCOshLjLnEjhP97dqacMuDQc-e914QHB9Nun3PdRnwJI2SlWeIMdYusoaalWwpoyJkRtLQSuJIGuEz2Y6NT4XyDTMxs4ipIFIGQgqmVMJC-9k7aJOA_6SBNjtH49OzUhRY4ZC3_PVjP4B30qCMvKcUnA7BPmR9BiysycS8dUAlIO5egml-Pf2TAvx7HOcNwXj8GD1yGi0-LEjwCdowiy10b-Te7LfQw8IziIuEp6foew9q9bo2W1hkCvcW6wt8ppegyloaxDODO0URafvdU6uiziyVL3FJSVph8B7jITR4g3FlrACeQMoXHrj4sgxPM9x1yer5RFbZxUW5Zpij--nLoOf5CbaYAKmty8KrmZ-hyW0c6XPUyGaZfokwSZVKWZgKFqXEhKA_BVGSyFgGbc1k1ETvy5Pj0hVVh94eX3luXFHK4Zy5O-cm2quw50Uxkb_gdYAIKhwoAZ7_MFtccMdReJvESiZBLFOrVSbgTtQ6lszXhAqZUr-JdoCEeJFPWzEyfsh8AlUOQ9ZE73IMYGV20VK4jAy7dSgKVsPcrmHK-fSK34C2alDLoGRt8K4j4v9sulVSOHd8dMl_3fomeluBYQKIDcz0bJ3jRAmxKBbnRXEhqolCCg0WYHRcuyq1v7YOyaaXeZV1lkQ0Dsmrfy9rB93vT0ZDPhyMT7bRA9gQRCgGSQs1Vou1fm1V1lX6xjEGjPgts6KfxBCmeQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3bbtMw1BpDTEgIwbiVFWakTTygqI0TJ84DQltLtbILExqob5bj2FsllHS9aOKzeOTvOCdxwoK4PO215zi26-Nz87kQssP7AeO6bzwVZ9wLU2U9lUXWS4zhJua-thwTnI9PooPP4YcJn6yRH3UuDIZV1jyxZNRZodFH3sNILBBGkR_1rAuLOB2O3s0uPewghS-tdTuNikQOzbcrMN8Wb8dDOOtdxkbvzwYHnusw4GkeJUvPhtaCTQRGGki1VHAVCKt5AFI40lb5Qvdj63OV-VbYWABiqkKtmdJKZFkiAvjsLXI7DsIQu0bEk8bWA7FQNvv1Y5_hCymrY-45R3cD62G-JxNBSxqWTQMa0XDnAo3yq-mfVN_fIzivicTRA3Lf6bJ0ryK-h2TNzjfJxrF7rd8k9yqfIK1SnR6R70Os0usabFGVZ3Q4X53TT2aBSixQHy0s3a_KR8N3T0E5LYC-F7SmIZNR9BvTI2zthuPqKAF6hsledOwiy3I6zenApamXE4GaS6tCzTjH4OOX8dDzEwqYCGmtC-DNzI_J2U0c6BOynhe5eUZomGZZKoJUiSgNbYCaE4uSRMea9Y3QUYe8qU9OaldOHbt6fJWlWcW5xHOW7pw7ZLfBnlVlRP6Ct49E0OBg8e_yh2J-Lh0vkf0wznTCYp2CPpmgI9GYWAvfhFzplPsdso0kJKtM2oaFyT3hh1jfMBAd8rrEQCYGi9bK5WLA1rEcWAtzq4WpZ9NLeQ3abUGBNenW4B1HxP_ZdLemcOk46EL-uu8d8qoB4wQYFZibYlXiREkIKIDztLoQzUQBx9YKODpuXZXWX9uG5NOLsr66SCIOd_r5v5e1TTaAAcmj8cnhFrmL-8HQRJZ0yfpyvjIvQFddpi9LrkCJvGEu9BMuFKQV |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Distribution+and+Drug+Resistance+of+Bacterial+Pathogens+Associated+with+Lower+Respiratory+Tract+Infection+in+Children+and+the+Effect+of+COVID-19+on+the+Distribution+of+Pathogens&rft.jtitle=The+Canadian+journal+of+infectious+diseases+%26+medical+microbiology&rft.au=Zhu%2C+Xuan&rft.au=Ye%2C+Ting&rft.au=Zhong%2C+Hong&rft.au=Luo%2C+Yaxuan&rft.date=2022-03-29&rft.issn=1712-9532&rft.volume=2022&rft.spage=1181283&rft_id=info:doi/10.1155%2F2022%2F1181283&rft_id=info%3Apmid%2F35368516&rft.externalDocID=35368516 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1712-9532&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1712-9532&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1712-9532&client=summon |